MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202517014098 A) filed by Qurient Co. Ltd., Gyeonggi, Republic of Korea, on Feb. 19, for 'combination therapy of cdk7 inhibitors with other anti-cancer therapies.'
Inventor(s) include Nam, Kiyean; Kim, Jaeseung; Jeon, Yeejin; Yu, Donghoon; Ahn, Won-Gyun; and Lee, Seung-Joo.
The application for the patent was published on March 7, under issue no. 10/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to combinations of cyclin-dependent kinase 7 (CDK7) inhibitors and other therapeutic treatments, in particular other anti-cancer agents, and uses of such combination(s) in the treatment of cancers."...